Neuropathy Clinical Trial
— FINSOfficial title:
Lower Extremity Fixation In Neuropathic Patients Study
Verified date | June 2023 |
Source | Stryker Trauma GmbH |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Prospective, multi-site, multi-year post-market clinical follow-up study on neuropathic patients treated/implanted with SALVATION™ External Fixation, SALVATION™ Fusion Bolts and Beams, SALVATION™ Midfoot Nail, The SALVATION™ 3Di Plating System, and/or VALOR™ NAIL of 200 patients with up to 10 sites
Status | Terminated |
Enrollment | 41 |
Est. completion date | October 28, 2022 |
Est. primary completion date | October 28, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years and older |
Eligibility | Inclusion Criteria: - Willing and able to consent to participate (written, informed consent); - Willing and able to attend/complete the requested follow-up visits; - Considered for treatment for Neuropathy with SALVATION™ External Fixation, SALVATION™ Fusion Bolts and Beams, SALVATION™ Midfoot Nail, The SALVATION™ 3Di Plating System, and/or VALOR™ NAIL Exclusion Criteria: - Subjects determined, by the investigator, to be an inappropriate candidate for the procedure indicated; - Unable to consent to participate (written, informed consent); - Unable to attend/complete the requested follow-up visits |
Country | Name | City | State |
---|---|---|---|
United States | Central Tennessee Foot and Ankle Center | Sparta | Tennessee |
United States | Florida Joint Care Institute | Trinity | Florida |
United States | Premier Orthopaedic and Sports Medicine | West Chester | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Stryker Trauma GmbH |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Survival Analysis of Implants at 3 years | Compare the pooled cumulative 3-year amputation (above or below the knee) rate of neuropathic patients implanted with SALVATION™ EXTERNAL FIXATION, SALVATION™ FUSION BOLTS AND BEAMS, SALVATION™ MIDFOOT NAIL, THE SALVATION™ 3DI PLATING SYSTEM, VALOR™ NAIL derived from a Kaplan-Meier survival analysis to a performance goal. | 3 years | |
Secondary | EQ-5D-5L | Evaluate improvements in patient-reported pain, function, and social interaction for quality of life from pre-op through each annual visit as assessed by the EQ-5D-5L and its component scores. Health state index scores generally range from less than 0 to 1 with higher scores indicating higher health utility. The health state preferences often represent national or regional values and can therefore differ between countries/regions. The second part of the questionnaire consists of a visual analogue scale (VAS) on which the patient rates his/her perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health). | 5 years | |
Secondary | Foot and Ankle Ability Measure (FAAM) | Evaluate improvements in patient-reported pain, function, and social interaction for quality of life from pre-op through each annual visit as assessed by the the FAAM and its component scores. The ADL and Sports subscales are scored separately. The scores for ADL can range from 0 to 84. The item score total is divided by the highest potential score. This value is then multiplied by 100 to get a percentage. A higher score represents a higher level of physical function. The scores for Sports subscale range from 0 to 32. The item score total is divided by the highest potential score. This value is then multiplied by 100 to get a percentage. A higher score represents a higher level of physical function. | 5 years | |
Secondary | Survival Analysis of Implants at 5 years | Compare the pooled cumulative 5-year amputation (above or below the knee) rate of neuropathic patients implanted with SALVATION™ EXTERNAL FIXATION, SALVATION™ FUSION BOLTS AND BEAMS, SALVATION™ MIDFOOT NAIL, THE SALVATION™ 3DI PLATING SYSTEM, VALOR™ NAIL derived from a Kaplan-Meier survival analysis to a performance goal. | 5 years | |
Secondary | Radiographic Assessment | Assess fusion and consolidation time of bony unions utilizing surgeon's evaluations of standard of care x-rays | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03195868 -
Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy
|
N/A | |
Not yet recruiting |
NCT05565469 -
Correlation Between Abdominal Wall Stimulation and Neurostimulator Tip Location
|
N/A | |
Completed |
NCT02309164 -
The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).
|
N/A | |
Completed |
NCT00775645 -
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
|
Phase 3 | |
Completed |
NCT03624426 -
Detection and Prevention of Nerve Injury in Shoulder Arthroplasty Surgery
|
N/A | |
Withdrawn |
NCT03436680 -
Home-Based Neurofeedback Program in Treating Participants With Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
Completed |
NCT05691738 -
Effects of Modified Otago Exercises in Individuals With Diabetic Neuropathy
|
N/A | |
Completed |
NCT05095870 -
Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
|
||
Completed |
NCT02615678 -
Acupuncture for CIPN in Breast Cancer Patients
|
N/A | |
Completed |
NCT02011282 -
Electro-Neuro-Muscular Stimulation in ICU
|
N/A | |
Recruiting |
NCT01774058 -
The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation
|
Phase 2 | |
Completed |
NCT01135251 -
Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy
|
Phase 2 | |
Recruiting |
NCT06324344 -
Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN)
|
N/A | |
Recruiting |
NCT04403802 -
Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
Recruiting |
NCT04579406 -
Perioperative Adverse Cardiovascular Event in Type-2 Diabetic Patients
|
||
Recruiting |
NCT03881930 -
Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy
|
N/A | |
Completed |
NCT03909464 -
Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy
|
||
Completed |
NCT01523132 -
Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms
|
N/A | |
Completed |
NCT02689661 -
Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects
|
||
Terminated |
NCT00998738 -
Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
|
Phase 3 |